Tag: Patient Enrollment

October 9, 2018

Hemostemix Announces Three Additional Sites Enrolled in Phase II Clinical Trial

Hemostemix (TSXV:HEM) is pleased to announce that it has received all approvals from three new medical centers to be clinical trial...
April 29, 2018

5 Top Weekly NASDAQ Biotech Stocks: Eleven Biotherapeutics Up 45 Percent

Eleven Biotherapeutics, EyePoint Pharmaceuticals, Avid Bioservices, Cerecor and Celldex were last week's top gainers on the NASDAQ.
April 25, 2018

U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery

Pluristem Therapeutics (Nasdaq:PSTI) a leading developer of placenta-based cell therapy products, announced today that the U.S. Food and Drug Administration (FDA)...
April 19, 2018

FDA Clinical Trial Approval Spikes Hemostemix’s Share Price

The cell-therapy company's share price increased by over 90 percent after the milestone announcement was released on Thursday.
April 17, 2018

Biomerica Announces Third Quarter Financial Results

Biomerica (Nasdaq:BMRA) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for...
April 6, 2018

EyeGate Completes Enrollment and Receives Milestone Payment for Confirmatory Phase 3 Clinical Study of EGP-437

EyeGate Pharmaceuticals (NASDAQ:EYEG) announced completion of patient enrollment for the pivotal Phase 3 clinical study of its EGP-437 combination product...
April 1, 2018

5 Top NASDAQ Biotech Stocks: Cardiome on Top

Cardiome, Avid, XBiotech, Fennec and Compugen were last week's five top-gaining NASDAQ biotech stocks. See what moved their share prices.